Valley National Advisers’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,000
| Closed | -$5K | – | 781 |
|
2024
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 594 |
|
2024
Q2 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 674 |
|
2024
Q1 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 619 |
|
2023
Q4 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 636 |
|
2023
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 660 |
|
2023
Q2 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 600 |
|
2023
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 624 |
|
2022
Q4 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 622 |
|
2022
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 628 |
|
2022
Q2 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 569 |
|
2022
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 630 |
|
2021
Q4 | $10K | Hold |
1,000
| – | – | ﹤0.01% | 601 |
|
2021
Q3 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 497 |
|
2021
Q2 | $18K | Buy |
+1,000
| New | +$18K | ﹤0.01% | 503 |
|
2021
Q1 | – | Sell |
-2,000
| Closed | -$34K | – | 880 |
|
2020
Q4 | $34K | Buy |
+2,000
| New | +$34K | 0.01% | 357 |
|